MyD88 acts as an adaptor protein for inflammatory signalling induced by amyloid-β in macrophages

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 109-118

  O'Halloran, Sophie ^a   O'Leary, Alicia ^a   Kuijper, Teun ^a   Downer, Eric J ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

A ; Inflammation; Innate immunity; Macrophage; MyD88; TLR

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; AMYLOID BETA PROTEIN; TOLL LIKE RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL IMMORTALIZATION; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; INNATE IMMUNITY; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; DEFICIENCY; GENE INACTIVATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; GENE KNOCKOUT TECHNIQUES; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908348185     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.08.001     Document Type: Article

References (79)

1. Haga S., Akai K., Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 1989, 77:569-575.
2. Simard A.R., Soulet D., Gowing G., Julien J.P., Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006, 49:489-502.
3. Graber D.J., Hickey W.F., Harris B.T. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinflamm 2010, 7:8.
4. Hendriks J.J., Teunissen C.E., de Vries H.E., Dijkstra C.D. Macrophages and neurodegeneration. Brain Res Brain Res Rev 2005, 48:185-195.
5. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011, 11:762-774.
6. Britschgi M., Wyss-Coray T. Immune cells may fend off Alzheimer disease. Nat Med 2007, 13:408-409.
7. Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 2006, 83:711-730.
8. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253-263.
9. Kenny E.F., O'Neill L.A. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008, 43:342-349.
10. Moynagh P.N. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol 2005, 26:469-476.
11. O'Neill L.A. TLRs: Professor Mechnikov, sit on your hat. Trends Immunol 2004, 25:687-693.
12. Li X., Jiang S., Tapping R.I. Toll-like receptor signaling in cell proliferation and survival. Cytokine 2010, 49:1-9.
13. Letiembre M., Hao W., Liu Y., Walter S., Mihaljevic I., Rivest S., et al. Innate immune receptor expression in normal brain aging. Neuroscience 2007, 146:248-254.
14. Vollmar P., Kullmann J.S., Thilo B., Claussen M.C., Rothhammer V., Jacobi H., et al. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system. J Immunol 2010, 185:6338-6347.
15. Song M., Jin J., Lim J.E., Kou J., Pattanayak A., Rehman J.A., et al. TLR4 mutation reduces microglial activation, increases Abeta deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease. J Neuroinflamm 2011, 8:92.
16. Jana M., Palencia C.A., Pahan K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. J Immunol 2008, 181:7254-7262.
17. Michaud J.P., Richard K.L., Rivest S. MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease. Mol Neurodegener 2011, 6:5.
18. Roberson S.M., Walker W.S. Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. Cell Immunol 1988, 116:341-351.
19. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008, 9:847-856.
20. Jones R.S., Minogue A.M., Connor T.J., Lynch M.A. Amyloid-beta-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE. J Neuroimmun Pharmacol 2013, 8:301-311.
21. Minogue A.M., Lynch A.M., Loane D.J., Herron C.E., Lynch M.A. Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid. J Neurochem 2007, 103:914-926.
22. Lyons A., Downer E.J., Costello D.A., Murphy N., Lynch M.A. Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia. J Neuroinflamm 2012, 9:107.
23. Lyons A., Griffin R.J., Costelloe C.E., Clarke R.M., Lynch M.A. IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro. J Neurochem 2007, 101(3):771-781.
24. Murphy K.J., Miller A.M., Thelma R., Cowley F., Cox F.F., Lynch M.A. The age- and amyloid-beta-related increases in Nogo B contribute to microglial activation. Neurochem Int 2011, 58:161-168.
25. Sanchez D., Rojas M., Hernandez I., Radzioch D., Garcia L.F., Barrera L.F. Role of TLR2- and TLR4-mediated signaling in Mycobacterium tuberculosis-induced macrophage death. Cell Immunol 2010, 260:128-136.
26. Naert G., Rivest S. The role of microglial cell subsets in Alzheimer's disease. Curr Alzheimer Res 2011, 8:151-155.
27. Naert G., Rivest S. Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. Mol Med 2012, 18:297-313.
28. Stalder A.K., Ermini F., Bondolfi L., Krenger W., Burbach G.J., Deller T., et al. Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci 2005, 25:11125-11132.
29. Simard A.R., Rivest S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J 2004, 18:998-1000.
30. Biju K., Zhou Q., Li G., Imam S.Z., Roberts J.L., Morgan W.W., et al. Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease. Mol Ther 2010, 18:1536-1544.
31. Smits H.A., van Beelen A.J., de Vos N.M., Rijsmus A., van der Bruggen T., Verhoef J., et al. Activation of human macrophages by amyloid-beta is attenuated by astrocytes. J Immunol 2001, 166:6869-6876.
32. Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014, 6:13.
33. Hanke M.L., Angle A., Kielian T. MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection. PLOS ONE 2012, 7:e42476.
34. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 2009, 210:3-12.
35. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006, 3:27.
36. Varnum M.M., Ikezu T. The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch Immunol Ther Exp (Warsz) 2012, 60:251-266.
37. Yang Y., Zhang R., Xia F., Zou T., Huang A., Xiong S., et al. LPS converts Gr-1(+)CD115(+) myeloid-derived suppressor cells from M2 to M1 via P38 MAPK. Exp Cell Res 2013, 319:1774-1783.
38. Muzio M., Bosisio D., Polentarutti N., D'Amico G., Stoppacciaro A., Mancinelli R., et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000, 164:5998-6004.
39. Aravalli R.N., Peterson P.K., Lokensgard J.R. Toll-like receptors in defense and damage of the central nervous system. J Neuroimmun Pharmacol 2007, 2:297-312.
40. Jack C.S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005, 175:4320-4330.
41. Mishra B.B., Gundra U.M., Teale J.M. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. J Neuroinflamm 2008, 5:53.
42. Ma Y., Li J., Chiu I., Wang Y., Sloane J.A., Lu J., et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 2006, 175:209-215.
43. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129:3006-3019.
44. Reed-Geaghan E.G., Savage J.C., Hise A.G., Landreth G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci 2009, 29:11982-11992.
45. Suh E.C., Jung Y.J., Kim Y.A., Park E.M., Lee S.J., Lee K.E. Knockout of Toll-like receptor 2 attenuates Abeta25-35-induced neurotoxicity in organotypic hippocampal slice cultures. Neurochem Int 2013, 63:818-825.
46. Qi Y., Zou L.B., Wang L.H., Jin G., Pan J.J., Chi T.Y., et al. Xanthoceraside inhibits pro-inflammatory cytokine expression in Abeta25-35/IFN-gamma-stimulated microglia through the TLR2 receptor, MyD88, nuclear factor-kappaB, and mitogen-activated protein kinase signaling pathways. J Pharmacol Sci 2013, 122:305-317.
47. Richard K.L., Filali M., Prefontaine P., Rivest S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 2008, 28:5784-5793.
48. Zhang W., Wang L.Z., Yu J.T., Chi Z.F., Tan L. Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease. J Neurol Sci 2012, 315:67-71.
49. Downer E.J., Jones R.S., McDonald C.L., Greco E., Brennan S., Connor T.J., et al. Identifying early inflammatory changes in monocyte-derived macrophages from a population with IQ-discrepant episodic memory. PLOS ONE 2013, 8:e63194.
50. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001, 413:78-83.
51. Lim J.E., Song M., Jin J., Kou J., Pattanayak A., Lalonde R., et al. The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice. Behav Brain Res 2012, 227:36-42.
52. Michaud J.P., Richard K.L., Rivest S. Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's disease. Stem Cell Rev 2012, 8:898-904.
53. Esen N., Kielian T. Central role for MyD88 in the responses of microglia to pathogen-associated molecular patterns. J Immunol 2006, 176:6802-6811.
54. Tseng W.P., Su C.M., Tang C.H. FAK activation is required for TNF-alpha-induced IL-6 production in myoblasts. J Cell Physiol 2010, 223:389-396.
55. Redhu N.S., Saleh A., Halayko A.J., Ali A.S., Gounni A.S. Essential role of NF-kappaB and AP-1 transcription factors in TNF-alpha-induced TSLP expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2011, 300:L479-L485.
56. Hoareau L., Bencharif K., Rondeau P., Murumalla R., Ravanan P., Tallet F., et al. Signaling pathways involved in LPS induced TNFalpha production in human adipocytes. J Inflamm (Lond) 2010, 7:1.
57. Chong Y.H., Shin Y.J., Suh Y.H. Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: involvement of multiple intracellular pathways and cyclic AMP response element binding protein. Mol Pharmacol 2003, 63:690-698.
58. Jang J.H., Surh Y.J. AP-1 mediates beta-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways. Biochem Biophys Res Commun 2005, 331:1421-1428.
59. Roy R., Singh S.K., Das M., Tripathi A., Dwivedi P.D. Toll-like receptor 6 mediated inflammatory and functional responses of zinc oxide nanoparticles primed macrophages. Immunology 2014, 142:453-464.
60. McDonald D.R., Bamberger M.E., Combs C.K., Landreth G.E. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 1998, 18:4451-4460.
61. Fogarty M.P., Downer E.J., Campbell V. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons. Biochem J 2003, 371:789-798.
62. Smits H.A., de Vos N.M., Wat J.W., van der Bruggen T., Verhoef J., Nottet H.S. Intracellular pathways involved in TNF-alpha and superoxide anion release by Abeta(1-42)-stimulated primary human macrophages. J Neuroimmunol 2001, 115:144-151.
63. Giri R.K., Selvaraj S.K., Kalra V.K. Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol 2003, 170:5281-5294.
64. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997, 88:213-222.
65. Zhang D., Facchinetti V., Wang X., Huang Q., Qin J., Su B. Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways. EMBO J 2006, 25:97-107.
66. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001, 412:346-351.
67. Matsuzawa A., Saegusa K., Noguchi T., Sadamitsu C., Nishitoh H., Nagai S., et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005, 6:587-592.
68. Quah S.Y., Bergenholtz G., Tan K.S. Fusobacterium nucleatum induces cytokine production through Toll-like-receptor-independent mechanism. Int Endod J 2014, 47:550-559.
69. de Rivero Vaccari J.P., Brand F.J., Sedaghat C., Mash D.C., Dietrich W.D., Keane R.W. RIG-1 receptor expression in the pathology of Alzheimer's disease. J Neuroinflamm 2014, 11:67.
70. Chen K., Zhang L., Huang J., Gong W., Dunlop N.M., Wang J.M. Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells. J Leukoc Biol 2008, 83:1467-1475.
71. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010, 22:41-47.
72. Moreira L.O., El Kasmi K.C., Smith A.M., Finkelstein D., Fillon S., Kim Y.G., et al. The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls. Cell Microbiol 2008, 10:2067-2077.
73. Novikova L., Czymmeck N., Deuretzbacher A., Buck F., Richter K., Weber A.N., et al. Cell death triggered by Yersinia enterocolitica identifies processing of the proinflammatory signal adapter MyD88 as a general event in the execution of apoptosis. J Immunol 2014, 192:1209-1219.
74. Bauerfeld C.P., Rastogi R., Pirockinaite G., Lee I., Huttemann M., Monks B., et al. TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages. J Immunol 2012, 188:2847-2857.
75. Hacker H., Furmann C., Wagner H., Hacker G. Caspase-9/-3 activation and apoptosis are induced in mouse macrophages upon ingestion and digestion of Escherichia coli bacteria. J Immunol 2002, 169:3172-3179.
76. Tran T.M., Temkin V., Shi B., Pagliari L., Daniel S., Ferran C., et al. TNFalpha-induced macrophage death via caspase-dependent and independent pathways. Apoptosis 2009, 14:320-332.
77. Bhattacharjee R.N., Park K.S., Kumagai Y., Okada K., Yamamoto M., Uematsu S., et al. VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition. J Biol Chem 2006, 281:36897-36904.
78. Koudinova N.V. Alzheimer's amyloid beta oligomers and lipoprotein apoAbeta: mistaken identity is possible. Bioessays 2003, 25:1024. (author reply 1025).
79. Sugimoto H. Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis. Yakugaku Zasshi 2010, 130:521-526.